Cargando…

Retraction: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes

Detalles Bibliográficos
Autor principal:	Frontiers Editorial Office
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492050/ https://www.ncbi.nlm.nih.gov/pubmed/31106154 http://dx.doi.org/10.3389/fonc.2019.00324

Ejemplares similares

Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
por: Abdo, Joe, et al.
Publicado: (2017)

Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer
por: Office, Frontiers Editorial
Publicado: (2023)

Retraction: Mechanisms Contributing to the Generation of Mayer Waves
por: Frontiers Editorial Office,
Publicado: (2021)

Retraction: Effect of weekly long-acting growth hormone replacement therapy compared to daily growth hormone on children with short stature: a meta-analysis
por: Office, Frontiers Editorial
Publicado: (2023)

Retraction: Green Synthesis of Metallic Nanoparticles and Their Potential Applications to Treat Cancer
por: Frontiers Editorial Office,
Publicado: (2023)

Retraction: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
por: Frontiers Editorial Office,
Publicado: (2022)

Retraction: Activated carbons from winemaking biowastes for electrochemical double-layer capacitors
por: Frontiers Editorial Office,
Publicado: (2023)

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990
por: Frontiers Editorial Office
Publicado: (2023)

Retraction: pH responsive polymer micelles enhances inhibitory efficacy on metastasis of murine breast cancer cells
por: Frontiers Editorial Office
Publicado: (2023)

Retraction: Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum
por: Frontiers Editorial Office
Publicado: (2023)

Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells
por: Frontiers Editorial Office
Publicado: (2023)

Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
por: Frontiers Editorial Office,
Publicado: (2022)

Retraction: LacI-Family Transcriptional Regulator DagR Acts as a Repressor of the Agarolytic Pathway Genes in Streptomyces coelicolor A3(2)
por: Frontiers Editorial Office,
Publicado: (2022)

Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor
por: Frontiers Editorial Office,
Publicado: (2023)

Retraction: LINC00174 facilitates cell proliferation, cell migration and tumor growth of osteosarcoma via regulating the TGF-β/SMAD signaling pathway and upregulating SSH2 expression
por: Frontiers Editorial Office,
Publicado: (2023)

Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer
por: Frontiers Editorial Office,
Publicado: (2022)

Retraction: microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis via the MAPK Signaling Pathway Through Targeting SOCS1
por: Frontiers Editorial Office,
Publicado: (2022)

Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
por: Huang, Runkai, et al.
Publicado: (2022)

Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR
por: Pathology & Oncology Research Editorial Office,
Publicado: (2021)

The application of radiomics in esophageal cancer: Predicting the response after neoadjuvant therapy
por: Guo, Hai, et al.
Publicado: (2023)

Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
por: Awad, Seifeldin, et al.
Publicado: (2020)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review
por: Zhu, Jie, et al.
Publicado: (2022)

The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review
por: Han, Dan, et al.
Publicado: (2022)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
por: Elliott, Jessie A., et al.
Publicado: (2021)

Esophageal adenocarcinoma with metastasis to the prostatic urethra and bladder
por: Olawoyin, Olamide M., et al.
Publicado: (2023)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

The Impact of Preoperative Sarcopenia on Survival Prognosis in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Jin, Sheng-bo, et al.
Publicado: (2021)

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013)

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
por: Kosovec, Juliann E., et al.
Publicado: (2018)

A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy
por: Cao, Wuteng, et al.
Publicado: (2020)

Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study
por: Ouyang, Peilin, et al.
Publicado: (2020)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
por: Thrift, Aaron P., et al.
Publicado: (2012)

OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma
por: Wang, Qiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ktbjaahgjf701beoa71me4u5aa